Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 17Gastrointestinal 16Other 3Gynecologic 3Genitourinary 3Dermatologic 3CNS 3Breast 3Sarcoma 2Other solid neoplasm 2Other hematologic neoplasm 2Head & Neck 2Classical hematology 1

Conditions

Head and Neck Neoplasms 2604Squamous Cell Carcinoma of Head and Neck 1880Thyroid Neoplasms 705Nasopharyngeal Carcinoma 627Carcinoma, Non-Small-Cell Lung 478Mouth Neoplasms 424Breast Neoplasms 383Neoplasms 381Oropharyngeal Neoplasms 359Melanoma 339Lung Neoplasms 319Colorectal Neoplasms 307Carcinoma, Squamous Cell 283Neoplasm Metastasis 255Ovarian Neoplasms 254Laryngeal Neoplasms 253Salivary Gland Neoplasms 236Uterine Cervical Neoplasms 234Stomach Neoplasms 223Esophageal Neoplasms 222Nasopharyngeal Neoplasms 221Pancreatic Neoplasms 213Prostatic Neoplasms 203Carcinoma, Renal Cell 201Thyroid Nodule 179Thyroid Cancer, Papillary 178Urinary Bladder Neoplasms 163Sarcoma 160Recurrence 143Hypopharyngeal Neoplasms 143

Interventions

Megestrol Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Anorexia × Head & Neck × Clear all
NCT04430842 2023-01-18

Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S

Quadriga Biosciences, Inc.

Phase 1 Completed
15 enrolled
BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckOther solid neoplasmSarcomaThoracic

Sleepiness, Mesothelioma, Malignant, Anorexia, Astrocytoma, Urinary Bladder Neoplasms, Brain Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Glioblastoma, Head and Neck Neoplasms, Headache, Kidney Neoplasms, Liver Neoplasms, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Seizures, Speech Disorders, Stomach Neoplasms, Thymoma, Tongue Neoplasms, Urologic Neoplasms, Vomiting, Colorectal Neoplasms, Cholangiocarcinoma

NCT00006799 2021-09-09

Megestrol to Limit Weight Loss and Improve Quality of Life in Treating Patients With Head and Neck Cancer

Wake Forest University Health Sciences

Phase 3 Completed
13 enrolled
CNSHead & Neck

Squamous Cell Carcinoma of Head and Neck, Anorexia, Cachexia, Head and Neck Neoplasms, Esthesioneuroblastoma, Olfactory

Data powered by HemOnc (CC BY 4.0) Colophon âš¡